|
(AFFY) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
June 19, 2013
(The Market Financial,
5/7/13)
Hammered small cap biotech stocks are jumping today, another sign investors are searching for anything with even a faint pulse to buy. Affymax, Inc. (NASDAQ:AFFY) is trading at $1.10, +0.30 (37.48%)...(read more)
(Stock Blog Hub,
3/23/13)
Affymax, Inc. (AFFY) recently announced that it will reduce its total workforce by approximately 75% (230 employees). The company took this decision after it recalled all lots of Omontys...(read more)
(Benzinga,
11/1/11)
Affymax (NASDAQ: AFFY) is a small-cap biopharmaceutical company that focuses on various hostile diseases. It is trying to break into the mature pharmaceutical space, and it seems that investors...(read more)
Affymax (AFFY) Company Overview
There is no analysis for AFFY yet. But you can go to Wikinvest to help create one! |
| ||||||
